| Clinical data | |
|---|---|
| Drug class | Serotonin–norepinephrine–dopamine releasing agent |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C11H13NS |
| Molar mass | 191.29 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-APBT is amonoamine releasing agent (MRA) of thebenzothiophene family.[1][2] It acts specifically as a fairly well-balancedserotonin–norepinephrine–dopamine releasing agent (SNDRA), withEC50Tooltip half-maximal effective concentration values of 8.9 nM forserotonin, 21.6 nM fornorepinephrine, and 38.6 nM fordopamine in rat brainsynaptosomes.[2] 2-APBT was first described in thescientific literature by 2020.[1][2]
Thispsychoactive drug-related article is astub. You can help Wikipedia byadding missing information. |